AbbVie to provide multi-million-dollar financing to Voyager to develop and commercialize potential Parkinson's treatment.
Bausch Health swings to a loss in the fourth quarter but issues positive revenue guidance for fiscal 2019.
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
Medtronic raises its full-year earnings forecast above analysts' estimates.
This biotechnology company got it's start California. Watch 'Behind the Label' TheStreet's new video series to learn more.
Gilead Sciences says Selonsertib, a new drug for treating NASH, a type of liver disease, failed Phase 3 trials.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.